PNPLA3 and steatosis: With respect to genotype, importantly, the patatin-like phospholipase domain containing 3 (PNPLA3) I148M variant, which has a global prevalence of 30 to 50%, is known to impair hepatic lipid metabolism and mitochondrial function, contributing to the development of steatosis and liver injury [182,183].